Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 101–200 of 1,005
De Rosa, V., Galgani, M., Porcellini, A., Colamatteo, A., Santopaolo, M., Zuchegna, C., Romano, A., De Simone, S., Procaccini, C., La Rocca, C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3269 · Cited by 398
Yang, K., Shrestha, S., Zeng, H., Karmaus, P. W. F., Neale, G., Vogel, P., Guertin, D. A., Lamb, R. F., & Chi, H. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.015 · Cited by 394
“As for the stringent requirement of this pathway for Th2 cell differentiation, it is important to note that Th2 cell differentiation is metabolically demanding in that Th2 cells have the highest rate of glycolysis among all effector T cells examined (Michalek et al., 2011; Shi et al., 2011).”
BackgroundCTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
Zappasodi, R., Serganova, I., Cohen, I. J., Maeda, M., Shindo, M., Senbabaoglu, Y., Watson, M. J., Leftin, A., Maniyar, R., Verma, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03326-4 · Cited by 393
Ouimet, M., Ediriweera, H. N., Gundra, U. M., Sheedy, F. J., Ramkhelawon, B., Hutchison, S. B., Rinehold, K., van Solingen, C., Fullerton, M. D., Cecchini, K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81676 · Cited by 394
“org Volume 125 Number 12 December 2015 simultaneously reduce levels of the glucose transporter Glut1 and increase FAO (49).”
Gonçalves, P., Araújo, J. R., & Di Santo, J. P. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx029 · Cited by 393
Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy
Sukumar, M., Liu, J., Mehta, G. U., Patel, S. J., Roychoudhuri, R., Crompton, J. G., Klebanoff, C. A., Ji, Y., Li, P., Yu, Z., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.002 · Cited by 388
“…basic features of T cells, including cellular activation, proliferation, differentiation, effector function (Gerriets et al., 2015; Gerriets andRathmell, 2012;MacIver et al., 2013;Michalek et al., 2011a, 2011b; Pearce et al., 2009, 2013; Sena et al., 2013; Shi et al., 2011), andantitumor immunity.”
Raud, B., Roy, D. G., Divakaruni, A. S., Tarasenko, T. N., Franke, R., Ma, E. H., Samborska, B., Hsieh, W. Y., Wong, A. H., Stüve, P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.002 · Cited by 386
“This raises the possibility of off-target effects of etomoxir on cellular metabolism when used at high concentrations, such as those employed in many studies exploring FAO in immune cells (usually 40–200 mM) (Huang et al., 2014; Michalek et al., 2011; van der Windt et al., 2012, 2013; Wu et al., 2016).”
InfluentialAging, obesity, and inflammatory age-related diseases
Frasca, D., Blomberg, B. B., & Paganelli, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01745 · Cited by 371
“Th1 CD4+ T cells express high levels of membrane glucose transporters and are highly glycolytic (44), a trait supporting inflammatory responses.”
BackgroundIntegrating canonical and metabolic signalling programmes in the regulation of T cell responses
Pollizzi, K. N., & Powell, J. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3701 · Cited by 379
The ERK and JNK pathways in the regulation of metabolic reprogramming
Papa, S., Choy, P. M., & Bubici, C. (2019) · Oncogene · doi:10.1038/s41388-018-0582-8 · Cited by 381
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 374
Immunometabolism: From basic mechanisms to translation
Makowski, L., Chaib, M., & Rathmell, J. C. (2020) · Immunological Reviews · doi:10.1111/imr.12858 · Cited by 374
Self-citationSimilarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 373
“…they have also been shown to not require mTOR or SLC2A1 (GLUT1) that promote anabolic metabolism and to instead primarily utilize an oxidative metabolism of lipids and pyruvate (Beier et al., 2015; Delgoffe et al., 2009; Gerriets et al., 2015; Macintyre et al., 2014; Michalek et al., 2011).”
BackgroundSelf-citationEfferocytosis induces a novel SLC program to promote glucose uptake and lactate release
Morioka, S., Perry, J. S. A., Raymond, M. H., Medina, C. B., Zhu, Y., Zhao, L., Serbulea, V., Onengut-Gumuscu, S., Leitinger, N., Kucenas, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0735-5 · Cited by 363
Self-citationJiang, G.-M., Tan, Y., Wang, H., Peng, L., Chen, H.-T., Meng, X.-J., Li, L.-L., Liu, Y., Li, W.-F., & Shan, H. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0944-z · Cited by 365
“Whereas mTOR activation is low and AMPK levels are high, the naive T cells preferentially differentiate into Treg cells [74].”
BackgroundTreg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses
Shrestha, S., Yang, K., Guy, C., Vogel, P., Neale, G., & Chi, H. (2015) · Nature Immunology · doi:10.1038/ni.3076 · Cited by 364
Autophagy in the renewal, differentiation and homeostasis of immune cells
Clarke, A. J., & Simon, A. K. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0095-2 · Cited by 361
Rosenblum, M. D., Way, S. S., & Abbas, A. K. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.1 · Cited by 348
“Compared with effector T cells, T Reg cells express lower levels of glucose transporter 1 (GLUT1; also known as SLC2A1) and have higher basal lipid oxidation rates, which suggests that they primarily rely on fatty acid oxidation for their energy requirements 94 .”
Al-Khami, A. A., Zheng, L., Del Valle, L., Hossain, F., Wyczechowska, D., Zabaleta, J., Sanchez, M. D., Dean, M. J., Rodriguez, P. C., & Ochoa, A. C. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1344804 · Cited by 346
“that show increased levels of triglycerides, LDL-cholesterol, and VLDL-cholesterol in the circulation of cancer patients(33-35) and patients with other chronic inflammatory diseases.(29-36,37) However, the source of lipids in the tumor milieu remains elusive.”
BackgroundMethodResultPacella, I., Procaccini, C., Focaccetti, C., Miacci, S., Timperi, E., Faicchia, D., Severa, M., Rizzo, F., Coccia, E. M., Bonacina, F., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720113115 · Cited by 344
“First, in Tregs and Tconvs from tumor-bearing mice, we evaluated the expression levels of three selected genes, Pparg, Acacb, and Cpt1a, respectively required for FA storage, FAS, and FAO.”
BackgroundInfluentialPrinciples and therapeutic applications of adaptive immunity
Chi, H., Pepper, M., & Thomas, P. G. (2024) · Cell · doi:10.1016/j.cell.2024.03.037 · Cited by 330
Beyond a neurotransmitter: The role of serotonin in inflammation and immunity
Wu, H., Denna, T. H., Storkersen, J. N., & Gerriets, V. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.015 · Cited by 338
Self-citationLiu, T. F., Vachharajani, V. T., Yoza, B. K., & McCall, C. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362343 · Cited by 340
Emerging concepts of T cell metabolism as a target of immunotherapy
Chang, C.-H., & Pearce, E. L. (2016) · Nature Immunology · doi:10.1038/ni.3415 · Cited by 338
Glucose transporter 1 critically controls microglial activation through facilitating glycolysis
Wang, L., Pavlou, S., Du, X., Bhuckory, M., Xu, H., & Chen, M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0305-9 · Cited by 335
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Perl, A. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.172 · Cited by 332
Yang, Z., Fujii, H., Mohan, S. V., Goronzy, J. J., & Weyand, C. M. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130252 · Cited by 334
“Notably, functionally distinct T cell subsets are characterized by distinct metabolic programs (Finlay and Cantrell, 2011; Michalek et al., 2011).”
BackgroundThe complex role of adipokines in obesity, inflammation, and autoimmunity
Taylor, E. B. (2021) · Clinical Science · doi:10.1042/cs20200895 · Cited by 330
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
“By contrast, Treg cells do not rely on a high dose of glucose and can be induced by AMPK signaling to exert their immunesuppressive functions [213].”
BackgroundImmunometabolic Interplay in the Tumor Microenvironment
Kaymak, I., Williams, K. S., Cantor, J. R., & Jones, R. G. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.09.004 · Cited by 328
“For instance, T helper (Th) cells are highly glycolytic (Michalek et al., 2011; Shi et al., 2011), relying on the glucose transporter GLUT1 for inflammatory cell (i.e., Th1 and Th17) effector function, and GLUT1-mediated glycolysis in regulatory T (Treg) cells regulates the balance between…”
BackgroundImmunometabolism of regulatory T cells
Newton, R., Priyadharshini, B., & Turka, L. A. (2016) · Nature Immunology · doi:10.1038/ni.3466 · Cited by 329
Mitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses
Baixauli, F., Acín-Pérez, R., Villarroya-Beltrí, C., Mazzeo, C., Nuñez-Andrade, N., Gabandé-Rodriguez, E., Ledesma, M. D., Blázquez, A., Martin, M. A., Falcón-Pérez, J. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.020 · Cited by 326
“…Th2, and Th17 lineages display a ll Metabolism 22, 1–14, September 1, 2015 ª2015 Elsevier Inc. 11 strong bias toward glycolysis over mitochondrial metabolism, whereas Treg cells have a mixed metabolism involving glycolysis, lipid oxidation, andOXPHOS (Gerriets et al., 2015;Michalek et al., 2011).”
Reactive Oxygen Species: Involvement in T Cell Signaling and Metabolism
Franchina, D. G., Dostert, C., & Brenner, D. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.01.005 · Cited by 322
Metabolic regulation of inflammation
Gaber, T., Strehl, C., & Buttgereit, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.37 · Cited by 320
The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells
Omenetti, S., Bussi, C., Metidji, A., Iseppon, A., Lee, S., Tolaini, M., Li, Y., Kelly, G., Chakravarty, P., Shoaie, S., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.004 · Cited by 317
“However, these data were generated exclusively from in-vitro-differentiated Th17 cells (Michalek et al., 2011).”
BackgroundLachmandas, E., Boutens, L., Ratter, J. M., Hijmans, A., Hooiveld, G. J., Joosten, L. A. B., Rodenburg, R. J., Fransen, J. A. M., Houtkooper, R. H., van Crevel, R., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.246 · Cited by 314
Ray, J. P., Staron, M. M., Shyer, J. A., Ho, P.-C., Marshall, H. D., Gray, S. M., Laidlaw, B. J., Araki, K., Ahmed, R., Kaech, S. M., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.017 · Cited by 315
“Furthermore, aerobic glycolysis as part of anabolic metabolism is differentially regulated among effector, regulatory, and memory T cell subsets that have different immunological functions and bioenergetic demands (Dang et al., 2011; Michalek et al., 2011; Pearce et al., 2009; Shi et al., 2011).”
InfluentialT cell metabolic fitness in antitumor immunity
Siska, P. J., & Rathmell, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.007 · Cited by 312
Self-citationCrosstalk between glucose metabolism, lactate production and immune response modulation
Ye, L., Jiang, Y., & Zhang, M. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.11.001 · Cited by 306
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Willenborg, S., Sanin, D. E., Jais, A., Ding, X., Ulas, T., Nüchel, J., Popović, M., MacVicar, T., Langer, T., Schultze, J. L., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.004 · Cited by 310
Targeting metabolism to regulate immune responses in autoimmunity and cancer
Patel, C. H., Leone, R. D., Horton, M. R., & Powell, J. D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0032-5 · Cited by 306
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M. E., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 305
Self-citationMetabolic adaptation of lymphocytes in immunity and disease
Chapman, N. M., & Chi, H. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.012 · Cited by 305
Miska, J., Lee-Chang, C., Rashidi, A., Muroski, M. E., Chang, A. L., Lopez-Rosas, A., Zhang, P., Panek, W. K., Cordero, A., Han, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.029 · Cited by 304
“, 2014) and subsequent lipid oxidation are metabolically relevant for Tregs (Gerriets et al., 2015; Howie et al., 2017; Michalek et al., 2011); however, HIF-1α KO Treg resistance to Eto treatment highlights that Treg dependence on lipids is context dependent.”
BackgroundResultInfluentialRegulatory T cells in the treatment of disease
Sharabi, A., Tsokos, M. G., Ding, Y., Malek, T. R., Klatzmann, D., & Tsokos, G. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.148 · Cited by 297
Haist, M., Stege, H., Grabbe, S., & Bros, M. (2021) · Cancers · doi:10.3390/cancers13020210 · Cited by 295
“In contrast to Th cells and CTL, which rely largely on glycolysis, glucose transporter (GLUT)-1 expression, and on mammalian target of rapamycin (mTOR) signaling, to sustain their metabolic activity, Treg express low levels of GLUT-1, are negatively regulated by mTOR, and depend largely on oxidative phosphorylation an…”
BackgroundMetabolic and Epigenetic Coordination of T Cell and Macrophage Immunity
Phan, A. T., Goldrath, A. W., & Glass, C. K. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.016 · Cited by 293
“…which contains diet-derived antigens, commensal microbes and their metabolic byproducts, and local inflammatory signals, induces Treg cell differentiation through several mechanisms and modulates immune responses (Mucida et al., 2005; Sun et al., 2007; Arpaia et al., 2013; Atarashi et al., 2011).”
Glucose and Glutamine Metabolism Regulate Human Hematopoietic Stem Cell Lineage Specification
Oburoglu, L., Tardito, S., Fritz, V., de Barros, S. C., Merida, P., Craveiro, M., Mamede, J., Cretenet, G., Mongellaz, C., An, X., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.06.002 · Cited by 291
“Consistent with these data, blocking FAO only impairs the differentiation of Tregs (Michalek et al., 2011; Shi et al., 2011), whereas the maintenance of long-lived memory T cells depends on a switch in energy metabolism from glucose to fatty acid utilization (Pearce et al., 2009; van der Windt and…”
BackgroundInfluentialPD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Xu-Monette, Z. Y., Zhang, M., Li, J., & Young, K. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01597 · Cited by 288
T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy
Sharabi, A., & Tsokos, G. C. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0356-x · Cited by 290
The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function
Pompura, S. L., & Dominguez-Villar, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0817-349r · Cited by 288
Leptin Metabolically Licenses T Cells for Activation To Link Nutrition and Immunity
Saucillo, D. C., Gerriets, V. A., Sheng, J., Rathmell, J. C., & MacIver, N. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301158 · Cited by 282
“Activated T cells rely on increased glucose metabolism to survive, proliferate, and produce cytokines; therefore, changes in T cell metabolism can directly impact T cell function and fate (5, 6, 38, 39).”
BackgroundMethodInfluentialSelf-citationMitochondria as central hub of the immune system
Breda, C. N. D. S., Davanzo, G. G., Basso, P. J., Saraiva Câmara, N. O., & Moraes-Vieira, P. M. M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101255 · Cited by 279
The assembly of lipid droplets and their roles in challenged cells
Henne, W. M., Reese, M. L., & Goodman, J. M. (2018) · The EMBO Journal · doi:10.15252/embj.201898947 · Cited by 278
“If newly synthesized droplet proteins are diverted to the ER lumen instead of the cytosol, they still are able to target to droplets (Mishra et al , 2016).”
Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy
Liu, X., Hartman, C. L., Li, L., Albert, C. J., Si, F., Gao, A., Huang, L., Zhao, Y., Lin, W., Hsueh, E. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz6314 · Cited by 274
Ferreira, G. B., Vanherwegen, A.-S., Eelen, G., Gutiérrez, A. C. F., Van Lommel, L., Marchal, K., Verlinden, L., Verstuyf, A., Nogueira, T., Georgiadou, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.013 · Cited by 275
“…ACC and consequently stimulating carnitine palmitoyltransferase 1 (CPT1a), the rate-limiting enzyme in FAO, is crucial for Treg development, whereas the Akt/mTOR axis is a negative regulator of de novo Treg differentiation and population expansion (Michalek et al., 2011; Zeng et al., 2013).”
BackgroundMethodResultInfluentialRegulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
Kishore, M., Cheung, K. C. P., Fu, H., Bonacina, F., Wang, G., Coe, D., Ward, E. J., Colamatteo, A., Jangani, M., Baragetti, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.017 · Cited by 276
“…programs to support their survival and differentiation: T helper (Th)1, Th2, and Th17 cells express high surface amounts of glucose transporter Glut1 and are highly glycolytic, whereas Treg cells express low amounts of Glut1 and have high lipid oxidation rates in vitro (Michalek et al., 2011).”
BackgroundMetabolic control of regulatory T cell development and function
Zeng, H., & Chi, H. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.08.003 · Cited by 274
Beier, U. H., Angelin, A., Akimova, T., Wang, L., Liu, Y., Xiao, H., Koike, M. A., Hancock, S. A., Bhatti, T. R., Han, R., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-268409 · Cited by 275
Zhang, D., Jin, W., Wu, R., Li, J., Park, S.-A., Tu, E., Zanvit, P., Xu, J., Liu, O., Cain, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.001 · Cited by 272
Endothelial cell metabolism in health and disease: impact of hypoxia
Wong, B. W., Marsch, E., Treps, L., Baes, M., & Carmeliet, P. (2017) · The EMBO Journal · doi:10.15252/embj.201696150 · Cited by 270
“Indeed, glycolysis and fatty acid synthesis are signatures of certain T-cell subsets (T helper) (Michalek et al, 2011), while truncation of the TCA cycle is characteristic in M1-like macrophages (see above, Tannahill et al, 2013) and PPP flux is required for their polarization (Haschemi et al,…”
BackgroundTGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Shi, X., Yang, J., Deng, S., Xu, H., Wu, D., Zeng, Q., Wang, S., Hu, T., Wu, F., & Zhou, H. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01349-6 · Cited by 262
Kishton, R. J., Barnes, C. E., Nichols, A. G., Cohen, S., Gerriets, V. A., Siska, P. J., Macintyre, A. N., Goraksha-Hicks, P., de Cubas, A. A., Liu, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.008 · Cited by 260
“Mice were obtained from Jackson Laboratory or have been previously described (Gershon et al., 2013; Macintyre et al., 2014; Michalek et al., 2011).”
MethodSelf-citationTibbitt, C. A., Stark, J. M., Martens, L., Ma, J., Mold, J. E., Deswarte, K., Oliynyk, G., Feng, X., Lambrecht, B. N., De Bleser, P., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.014 · Cited by 260
Solute carrier transporters: the metabolic gatekeepers of immune cells
Song, W., Li, D., Tao, L., Luo, Q., & Chen, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.006 · Cited by 256
“These data are consistent with the theory of preferential glycolysis in Teffs and mitochondrial oxidation in Tregs described by Michalek et al.51.”
ResultKumagai, S., Togashi, Y., Sakai, C., Kawazoe, A., Kawazu, M., Ueno, T., Sato, E., Kuwata, T., Kinoshita, T., Yamamoto, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.016 · Cited by 257
Kundu, M., Butti, R., Panda, V. K., Malhotra, D., Das, S., Mitra, T., Kapse, P., Gosavi, S. W., & Kundu, G. C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01990-4 · Cited by 250
Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses
Kolev, M., Dimeloe, S., Le Friec, G., Navarini, A., Arbore, G., Povoleri, G. A., Fischer, M., Belle, R., Loeliger, J., Develioglu, L., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.024 · Cited by 255
“Effector T cells demand high levels of glycolysis, whereas Treg cells are more dependent on OXPHOS, and mTORC1 activity is required for Th1 and Th17 cell responses, whereas mTORC2 drives Th2 cell function (Delgoffe et al., 2009; Michalek et al., 2011; Shi et al., 2011).”
BackgroundProcaccini, C., Carbone, F., Di Silvestre, D., Brambilla, F., De Rosa, V., Galgani, M., Faicchia, D., Marone, G., Tramontano, D., Corona, M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.028 · Cited by 258
“Michaleck and colleagues showed that although Th1 and Th17 cells (which express high amounts of the glucose transporter Glut1) are highly glycolytic, Treg cells generated through in vitro polarization of CD4 T cells preferentially use lipid oxidation (Michalek et al., 2011; Gerriets et al., 2015).”
BackgroundHarnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
Targeting T cell metabolism for therapy
O'Sullivan, D., & Pearce, E. L. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.004 · Cited by 254
Inflammageing and metaflammation: The yin and yang of type 2 diabetes
Prattichizzo, F., De Nigris, V., Spiga, R., Mancuso, E., La Sala, L., Antonicelli, R., Testa, R., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.003 · Cited by 249
“For example, glycolysis and fatty acid synthesis are major features of T helper 1 (Th1) cells, whereas fatty acid oxidation is more prominent in regulatory T (Treg) cells (Michalek et al., 2011).”
Li, L., Liu, X., Sanders, K. L., Edwards, J. L., Ye, J., Si, F., Gao, A., Huang, L., Hsueh, E. C., Ford, D. A., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.020 · Cited by 245
Mitochondrial function in immune cells in health and disease
Faas, M. M., & de Vos, P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165845 · Cited by 246
Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs
Shi, L., Salamon, H., Eugenin, E. A., Pine, R., Cooper, A., & Gennaro, M. L. (2015) · Scientific Reports · doi:10.1038/srep18176 · Cited by 245
Cellular metabolism regulates the differentiation and function of T-cell subsets
Ma, S., Ming, Y., Wu, J., & Cui, G. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01148-8 · Cited by 236
“Pharmacological activation of AMP-activated protein kinase (AMPK) inhibits Glut1 expression, thereby promoting fatty acid oxidation and increasing FoxP3 expression, which is a lineage marker for Treg cells [101].”
BackgroundInfluentialAMPK α1: A glucose sensor that controls CD 8 T ‐cell memory
Rolf, J., Zarrouk, M., Finlay, D. K., Foretz, M., Viollet, B., & Cantrell, D. A. (2013) · European Journal of Immunology · doi:10.1002/eji.201243008 · Cited by 245
Comito, G., Iscaro, A., Bacci, M., Morandi, A., Ippolito, L., Parri, M., Montagnani, I., Raspollini, M. R., Serni, S., Simeoni, L., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0688-7 · Cited by 241
Liu, L., Lu, Y., Martinez, J., Bi, Y., Lian, G., Wang, T., Milasta, S., Wang, J., Yang, M., Liu, G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518000113 · Cited by 240
“In contrast, increased glycolysis is also seen in differentiating TH17 cells and during B-cell development in bone marrow, and this metabolic change is under the control of HIF1α (36, 47, 48).”
BackgroundHeterogeneity in Cancer Metabolism: New Concepts in an Old Field
Gentric, G., Mieulet, V., & Mechta-Grigoriou, F. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6750 · Cited by 240
Metabolism in physiological cell proliferation and differentiation
Agathocleous, M., & Harris, W. A. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.05.004 · Cited by 238
The liver kinase B1 is a central regulator of T cell development, activation, and metabolism
MacIver, N. J., Blagih, J., Saucillo, D. C., Tonelli, L., Griss, T., Rathmell, J. C., & Jones, R. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100367 · Cited by 235
Self-citationMcNamee, E. N., Korns Johnson, D., Homann, D., & Clambey, E. T. (2013) · Immunologic Research · doi:10.1007/s12026-012-8349-8 · Cited by 234
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
BackgroundMetabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy
Wang, H., Franco, F., & Ho, P.-C. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.06.005 · Cited by 234
Catch me if you can: how AML and its niche escape immunotherapy
Tettamanti, S., Pievani, A., Biondi, A., Dotti, G., & Serafini, M. (2022) · Leukemia · doi:10.1038/s41375-021-01350-x · Cited by 228
“Fatty acid abundance can hamper effector Tcell functions and promote Tregs differentiation [70].”
BackgroundMoro-García, M. A., Mayo, J. C., Sainz, R. M., & Alonso-Arias, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00339 · Cited by 234
“Similarly, the production of GLUT1 receptor, essential for the development of Th1 responses, is increased, whereas Tregs are unaffected by deficiency in this receptor and maintain their inhibitory capacity on T lymphocytes independently of GLUT1 (156).”
BackgroundRole of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus
Zhou, T., Hu, Z., Yang, S., Sun, L., Yu, Z., & Wang, G. (2018) · Journal of Diabetes Research · doi:10.1155/2018/7457269 · Cited by 229
“CD4+ T cells tend to polarize to Treg cells in vitro when treated with TGF-β, which appears to be dependent upon fatty acid oxidation and cholesterol metabolism rather than glycolysis [34, 35].”
BackgroundTargeting immune cells for cancer therapy
Gun, S. Y., Lee, S. W. L., Sieow, J. L., & Wong, S. C. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101174 · Cited by 229
“Furthermore, each CD4+ T effector and regulatory cell subset has a unique metabolic phenotype correlating to its Th1, Th2 or Th17 effector functions [233].”
BackgroundTargeting mTOR and Metabolism in Cancer: Lessons and Innovations
Magaway, C., Kim, E., & Jacinto, E. (2019) · Cells · doi:10.3390/cells8121584 · Cited by 225
Metabolism of activated T lymphocytes
Maciolek, J. A., Alex Pasternak, J., & Wilson, H. L. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.006 · Cited by 224
Araujo, L., Khim, P., Mkhikian, H., Mortales, C.-L., & Demetriou, M. (2017) · eLife · doi:10.7554/elife.21330 · Cited by 224
“iTreg cells induced by TGFb alone are non-glycolytic and utilize lipid oxidation for ATP production (Michalek et al., 2011; Shi et al., 2011).”
BackgroundInfluentialBifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade
Wang, F., Yin, Q., Chen, L., & Davis, M. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712901115 · Cited by 223
T cell Allorecognition Pathways in Solid Organ Transplantation
Siu, J. H. Y., Surendrakumar, V., Richards, J. A., & Pettigrew, G. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02548 · Cited by 223
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function
Sugiura, A., Andrejeva, G., Voss, K., Heintzman, D. R., Xu, X., Madden, M. Z., Ye, X., Beier, K. L., Chowdhury, N. U., Wolf, M. M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2021.10.011 · Cited by 219
Self-citationMastelic-Gavillet, B., Navarro Rodrigo, B., Décombaz, L., Wang, H., Ercolano, G., Ahmed, R., Lozano, L. E., Ianaro, A., Derré, L., Valerio, M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0719-5 · Cited by 216
Lactate and Immunosuppression in Sepsis
Nolt, B., Tu, F., Wang, X., Ha, T., Winter, R., Williams, D. L., & Li, C. (2018) · Shock · doi:10.1097/shk.0000000000000958 · Cited by 219
Foxp3 drives oxidative phosphorylation and protection from lipotoxicity
Howie, D., Cobbold, S. P., Adams, E., Ten Bokum, A., Necula, A. S., Zhang, W., Huang, H., Roberts, D. J., Thomas, B., Hester, S. S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89160 · Cited by 216
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy
Gupta, S., Roy, A., & Dwarakanath, B. S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00068 · Cited by 218
“Furthermore, phosphorylation and activation of a protein kinase unc-51 like kinase 1/2 (Ulk1/2) by AMPK is shown to connect energy sensing with autophagy (191).”
BackgroundInfluentialInflammatory microglia are glycolytic and iron retentive and typify the microglia in APP/PS1 mice
Holland, R., McIntosh, A. L., Finucane, O. M., Mela, V., Rubio-Araiz, A., Timmons, G., McCarthy, S. A., Gun'ko, Y. K., & Lynch, M. A. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.10.017 · Cited by 218
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.